IRADIMED CORPORATION IRMD
86.72 USD -0.22 (-0.25%)
At closeNov 10, 2026, 5:33 PM EST
86.72 0.00 0.00%
After hours · Nov 10, 5:33 PM ET
84.59 Day range 87.45
76.35 52-week range 107.90
- YTD
- -10.86%
- 1 year
- +0.76%
News
marketbeat.com What iRadimed (IRMD) Said on Its Q3 Earnings Call iRadimed NASDAQ: IRMD reported record third-quarter revenue as shipments of its newly launched 3870 MR IV pump accelerated, while the company said it is moderating its production ramp to protect…
seekingalpha.com IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript
benzinga.com iRadimed Q3 2026 Earnings Call Transcript iRadimed (NASDAQ:IRMD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period…
benzinga.com iRadimed Lowers FY2026 Adj EPS Guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 Est; Narrows FY2026 Sales Guidance from $91.000M-$96.000M to $91.600M-$93.100M vs $92.133M Est iRadimed (NASDAQ:IRMD) lowers FY2026 Adj EPS guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 analyst estimate. Narrows FY2026 sales outlook from $91.000 million-$96.000 million to $91.600…
benzinga.com iRadimed Sees Q4 Adj EPS $0.57-$0.61 vs $0.63 Est; Sees Sales $25.000M-$26.500M vs $26.233M Est iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.57-$0.61 vs $0.63 analyst estimate. sees sales of $25.000 million-$26.500 million vs $26.233 million analyst estimate.
globenewswire.com IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results Reports revenue of $24.2 million for the third quarter of 2026, which increased by $3.0 million, or 14% compared to the same period in 2025 and increased by $3.7 million or 18% compared to the second…
seekingalpha.com Riverwater Small Cap Strategy Q3 2026 Portfolio Update During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors…
defenseworld.net iRadimed (IRMD) Expected to Post Earnings on Friday iRadimed (NASDAQ: IRMD - Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to announce earnings of $0.55 per…
globenewswire.com IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026 ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on…
globenewswire.com IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference ORLANDO, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices,…
defenseworld.net Head-To-Head Contrast: iRadimed (NASDAQ:IRMD) & Medline (NASDAQ:MDLN) iRadimed (NASDAQ: IRMD - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on…
gurufocus.com iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100 On September 04, 2026, iRadimed Corp (IRMD) shares fell 3.8%, currently trading at $83.45. The stock has seen a notable decline, with a 52-week high of $107.90
defenseworld.net Algert Global LLC Sells 15,062 Shares of iRadimed Corporation $IRMD Algert Global LLC trimmed its stake in iRadimed Corporation (NASDAQ: IRMD) by 17.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
defenseworld.net iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of “Moderate Buy” by Brokerages Shares of iRadimed Corporation (NASDAQ: IRMD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five ratings firms that are presently covering the firm, MarketBeat…
marketbeat.com iRadimed Q2 Earnings Call Highlights iRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked…
seekingalpha.com IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
benzinga.com iRadimed Sees Q3 Adj EPS $0.54-$0.59 vs $0.52 Est; Sees Sales $23.000M-$24.500M vs $23.650M Est iRadimed (NASDAQ:IRMD) is looking for Q3 Adj EPS of $0.54-$0.59 vs $0.52 analyst estimate. sees sales of $23.000 million-$24.500 million vs $23.650 million analyst estimate.- benzinga.com CORRECTION: iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $91.300M Est iRadimed (NASDAQ:IRMD) raises FY2026 Adj EPS guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 analyst estimate. Raises FY2026 sales outlook from $91.000 million-$96.000 million to $91.000…
globenewswire.com IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by…
globenewswire.com IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026 ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on…
benzinga.com Elon Musk Confirms Starlink Can Deliver Reliable 10 Gigabit-a-Second Upload and Download Speeds Anywhere On Earth Elon Musk announced Starlink can now provide 10 Gbps global connectivity, a key step in satellite internet's push to high-speed data service.
fool.com IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance.
globenewswire.com IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and…
fool.com Why Iradimed Stock Topped the Market Today Yet again, it posted growth and robust profitability in its latest quarter.
gurufocus.com iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Tells Investors On May 01, 2026, iRadimed Corp (IRMD) shares rose 4.4%, bringing the current price to $87.15. This movement comes amid a 52-week range that has seen a high of $
seekingalpha.com IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
benzinga.com iRadimed Affirms FY2026 Adj EPS Guidance of $2.06-$2.21 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $92.346M Est iRadimed (NASDAQ:IRMD) affirms FY2026 Adj EPS guidance from $2.06-$2.21 to $2.06-$2.21 vs $2.08 analyst estimate. Affirms FY2026 sales outlook from $91.000 million-$96.000 million to $91.000…
benzinga.com iRadimed Sees Q2 Adj EPS $0.44-$0.48 vs $0.47 Est; Sees Sales $20.000M-$21.000M vs $21.134M Est iRadimed (NASDAQ:IRMD) is looking for Q2 Adj EPS of $0.44-$0.48 vs $0.47 analyst estimate. sees sales of $20.000 million-$21.000 million vs $21.134 million analyst estimate.- benzinga.com iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.45 by 8.89 percent. This is a 16.67 percent increase over earnings of $0.42 per…
benzinga.com Earnings Scheduled For May 1, 2026 
benzinga.com Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday 
benzinga.com iRadimed Raised Its Quarterly Dividend To $0.20/Share From $0.17/Share IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ:IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing…
benzinga.com iRadimed Q4 Earnings Summary & Key Takeaways - benzinga.com Earnings Scheduled For February 10, 2026
benzinga.com Uncovering Potential: iRadimed's Earnings Preview - benzinga.com iRadimed Declares $0.50/Share Special Cash Dividend Payable December 30, 2025 iRadimed Corporation (the "Company") (NASDAQ:IRMD), announced that its Board of Directors (the "Board") approved a special cash dividend of $0.50 per share of the Company's outstanding common stock.…
- benzinga.com iRadimed Sees Q4 Adj EPS $0.47-$0.51 vs $0.47 Est; Sees Sales $21.400M-$22.400M vs $20.733M Est iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.47-$0.51 vs $0.47 analyst estimate. sees sales of $21.400 million-$22.400 million vs $20.733 million analyst estimate.
- benzinga.com iRadimed Raises FY2025 Adj EPS Guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 Est; Raises FY2025 Sales Guidance from $80.000M-$82.500M to $82.500M-$83.500M vs $81.091M Est iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 sales outlook from $80.000 million-$82.500 million to $82.500…
- benzinga.com iRadimed Q3 Adj. EPS $0.47 Beats $0.46 Estimate, Sales $21.202M Beat $20.498M Estimate iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 3.3 percent. This is a 9.3 percent increase over earnings of $0.43 per…
benzinga.com Earnings Scheduled For November 3, 2025 - benzinga.com Earnings Scheduled For August 1, 2025
- benzinga.com Earnings Scheduled For May 5, 2025
- benzinga.com Earnings Scheduled For February 13, 2025
- benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
- benzinga.com Earnings Scheduled For November 3, 2023 Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.- benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
- benzinga.com Earnings Scheduled For November 3, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 517 companies set new 52-week lows.